ARK Genomic Revolution ETF vs SAP SE — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while SAP SE trades at $206.92 (market cap $240.81B). The key difference: SAP SE pays a 1.4% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, SAP SE nearer its low. Which is the better fit depends on your goals.
| ARKG | SAP | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $280.46 |
52-Week Low | $24.02 | $146.38 |
Market Cap | — | $240.81B |
Enterprise Value | — | $239.52B |
Dividend Yield | — | 1.4% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →